Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Vaccine Efficacy in Adults in a Respiratory Syncytial Virus Challenge Study.
N Engl J Med. 2022 Jun 23;386(25):2377-2386. doi: 10.1056/NEJMoa2116154.
N Engl J Med. 2022.
PMID: 35731653
Clinical Trial.
Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F Vaccine When Coadministered With a Tetanus, Diphtheria, and Acellular Pertussis Vaccine.
Peterson JT, Zareba AM, Fitz-Patrick D, Essink BJ, Scott DA, Swanson KA, Chelani D, Radley D, Cooper D, Jansen KU, Dormitzer PR, Gruber WC, Gurtman A.
Peterson JT, et al. Among authors: zareba am.
J Infect Dis. 2022 Jun 15;225(12):2077-2086. doi: 10.1093/infdis/jiab505.
J Infect Dis. 2022.
PMID: 34637519
Free PMC article.
Clinical Trial.
Item in Clipboard
Phase 1/2 Randomized Study of the Immunogenicity, Safety, and Tolerability of a Respiratory Syncytial Virus Prefusion F Vaccine in Adults With Concomitant Inactivated Influenza Vaccine.
Falsey AR, Walsh EE, Scott DA, Gurtman A, Zareba A, Jansen KU, Gruber WC, Dormitzer PR, Swanson KA, Jiang Q, Gomme E, Cooper D, Schmoele-Thoma B.
Falsey AR, et al.
J Infect Dis. 2022 Jun 15;225(12):2056-2066. doi: 10.1093/infdis/jiab611.
J Infect Dis. 2022.
PMID: 34931667
Free PMC article.
Clinical Trial.
Item in Clipboard
A Randomized Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine.
Walsh EE, Falsey AR, Scott DA, Gurtman A, Zareba AM, Jansen KU, Gruber WC, Dormitzer PR, Swanson KA, Radley D, Gomme E, Cooper D, Schmoele-Thoma B.
Walsh EE, et al. Among authors: zareba am.
J Infect Dis. 2022 Apr 19;225(8):1357-1366. doi: 10.1093/infdis/jiab612.
J Infect Dis. 2022.
PMID: 34932102
Free PMC article.
Clinical Trial.
Item in Clipboard
Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults.
Walsh EE, Pérez Marc G, Zareba AM, Falsey AR, Jiang Q, Patton M, Polack FP, Llapur C, Doreski PA, Ilangovan K, Rämet M, Fukushima Y, Hussen N, Bont LJ, Cardona J, DeHaan E, Castillo Villa G, Ingilizova M, Eiras D, Mikati T, Shah RN, Schneider K, Cooper D, Koury K, Lino MM, Anderson AS, Jansen KU, Swanson KA, Gurtman A, Gruber WC, Schmoele-Thoma B; RENOIR Clinical Trial Group.
Walsh EE, et al. Among authors: zareba am.
N Engl J Med. 2023 Apr 20;388(16):1465-1477. doi: 10.1056/NEJMoa2213836. Epub 2023 Apr 5.
N Engl J Med. 2023.
PMID: 37018468
Clinical Trial.
Item in Clipboard
Respiratory Syncytial Virus Prefusion F Vaccination: Antibody Persistence and Revaccination.
Walsh EE, Falsey AR, Zareba AM, Jiang Q, Gurtman A, Radley D, Gomme E, Cooper D, Jansen KU, Gruber WC, Swanson KA, Schmoele-Thoma B.
Walsh EE, et al. Among authors: zareba am.
J Infect Dis. 2024 Apr 12:jiae185. doi: 10.1093/infdis/jiae185. Online ahead of print.
J Infect Dis. 2024.
PMID: 38606958
Item in Clipboard
Lead exposure of children from copper industry pollution.
Zareba A, Rudkowski Z.
Zareba A, et al.
Arch Environ Health. 1996 Nov-Dec;51(6):480-1. doi: 10.1080/00039896.1996.9936052.
Arch Environ Health. 1996.
PMID: 9012335
No abstract available.
Item in Clipboard
Cite
Cite